The interruption that froze half the U.S. stock market last week began with a routine notice.
��YSE Arca is currently experiencing an issue processing customer messages on routed orders in Tape C symbol range ��ACT�� through ��YY.C,��� read an alert for traders received by Bloomberg News at 10:17 a.m. on Aug. 22. ��ill advise.��
The brevity of the message belied its significance. Computers at the world�� biggest exchange operators were having difficulty communicating. Within two hours, trading stopped in more than 2,000 U.S. stocks. The three-hour shutdown was the latest in a series of failures to disrupt increasingly complicated markets, prompting the Securities and Exchange Commission to push for rules requiring executives to improve the reliability of their technology.
��very time we have a glitch like this, it just knocks a little bit more investor confidence off the table,��said Seth Merrin, chief executive officer of Liquidnet Holdings Inc., a private trading platform that competes with the public exchanges, in an interview on Bloomberg Television. ��his kind of scenario should have been thought of and practiced between all of the different participants.��
Top 10 Tech Companies To Watch In Right Now: Durata Therapeutics Inc (DRTX)
Durata Therapeutics, Inc., incorporated on November 4, 2009, is a pharmaceutical company focused on the development and commercialization of therapeutics for patients with infectious diseases and acute illnesses. The Company enroll and dose patients in two global Phase III clinical trials with its product candidate, dalbavancin, for the treatment of patients with acute bacterial skin and skin structure infections (abSSSI). Dalbavancin is an intravenous antibiotic product candidate designed for once-weekly dosing. In addition to abSSSI, the Company focuses on the development of dalbavancin for additional indications, including osteomyelitis, diabetic foot infection and pneumonia.
As of December 31, 2011, Dalbavancin had already completed three Phase III clinical trials, in which more than 1,000 patients in total received dalbavancin. Dalbavancin achieved its primary efficacy endpoint of non-inferiority in each of these three completed Phase III clinical trials when compared to linezolid, cefazolin or vancomycin, three of the standard-of-care agents for uncomplicated skin and skin structure infections (uSSSI), and complicated skin and skin structure infections (cSSSI). Its two ongoing Phase III clinical trials are designed to compare dalbavancin to vancomycin, with an option to switch to oral linezolid, under the new FDA draft guidance.
The Company competes with Pfizer, Cubist Pharmaceuticals, Inc., Theravance, Inc., Forest Laboratories, Inc., Sanofi-Aventis Ltd., The Medicines Company, Trius Therapeutics, Inc., Cempra, Inc., Rib-X Pharmaceuticals, Inc., Paratek Pharmaceuticals, Inc., Nabriva Therapeutics AG, Tetraphase Pharmaceuticals, Inc. and Furiex Pharmaceuticals, Inc.
Advisors' Opinion:- [By Bob's Stocks]
Durata Therapeutics (DRTX) is developing Dalbavancin, a once a week, intravenous antibiotic product candidate, for the treatment of patients with acute bacterial skin and skin structure infections, or ABSSSI. The company is expected to file a NDA (New Drug Application) at any moment and MAA (Marketing Authorization Application) at the end of 2013.
- [By Lisa Levin]
Durata Therapeutics (NASDAQ: DRTX) shares climbed 5.30% to $14.18. The volume of Durata Therapeutics shares traded was 861% higher than normal. The FDA Advisory Committee unanimously recommended the approval of Durata's Dalvance.
Top 10 Tech Companies To Watch In Right Now: Osiris Therapeutics Inc.(OSIR)
Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing of therapeutic products to treat various medical conditions in the inflammatory, autoimmune, orthopedic, and cardiovascular areas. It operates in two business segments, Therapeutics and Biosurgery. The Therapeutics segment focuses on developing biologic stem cell drug candidates from a readily available and non-controversial source, adult bone marrow. The Biosurgery segment works to harness the ability of cells and novel constructs to promote the body's natural healing. This segment focuses on developing biologic products for use in surgical procedures. The company?s lead biologic drug candidate is Prochymal, which is in phase 2 and 3 clinical trails for various indications, including acute graft versus host disease (GvHD), Crohn's disease, acute myocardial infarction, type 1 diabetes, pulmonary disease, and gastrointestinal injury resulting from radiation exposure. Its biologic drug candidates also include Chondrogen, a preparation of adult mesenchymal stem cells that is in phase 2 clinical trials for osteoarthritis and cartilage protection. The company has collaboration agreements with Genzyme Corporation for the development and commercialization of Prochymal and Chondrogen in various countries except in the United States and Canada. It also has a partnership with Juvenile Diabetes Research Foundation for the development of Prochymal as a treatment for the preservation of insulin production in patients with newly diagnosed type 1 diabetes mellitus. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.
Advisors' Opinion:- [By Alexander Maxwell]
One of the companies attempting to develop a better treatment for chronic diabetic foot ulcers is Osiris Therapeutics� (NASDAQ: OSIR ) . Earlier this month, Osiris shares more than doubled as the company announced positive data for its CDFU drug Grafix. The study results were very impressive to say the least; the study was stopped early due to the overwhelming efficacy exhibited by the treatment. A main highlight is the fact that 62% of Grafix patients had their wound closed at 12 weeks, compared to only 21% of patients using conventional methods. Clearly, the efficacy in this endpoint was overwhelming. Grafix also achieved all of the secondary endpoints for the trial, and more importantly demonstrated a relatively benign safety record.�
Top 5 Media Companies To Watch In Right Now: Neurocrine Biosciences Inc.(NBIX)
Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, stress-related disorders, pain, tardive dyskinesia, uterine fibroids, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. The company?s products in clinical development include Elagolix, a Phase II drug for endometriosis; Vesicular Monoamine Transporter 2 Inhibitor (VMAT2), a Phase II drug for movement disorders; CRF2 Peptide Agonist, a Phase II drug for cardiovascular diseases; CRF1 Antagonist, a Phase II drug for stress-related disorders; and Elagolix, a Phase II drug for uterine fibroids. Its research programs comprise G Protein-Coupled Receptor 119 (GPR119) for type II diabetes; VMAT2 for schizophrenia; GnRH Antagonists for men?s and women?s health, and oncology; Antiepileptic Drugs for epilepsy, essential tremor, and pain; and G Protein-Coupled Receptors for other conditions. The company has collaborations with GlaxoSmithKline to develop and commercialize CRF antagonists for psychiatric, neurological, and gastrointestinal diseases; Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize Indiplon in Japan; Abbott International Luxembourg S.�r.l. to develop and commercialize elagolix and GnRH antagonists for women?s and men?s health indications; and Boehringer Ingelheim International GmbH to research, develop, and commercialize small molecule GPR119 agonists for the treatment of type II diabetes and other indications. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.
Advisors' Opinion:- [By Ben Levisohn]
Somaiya and team named Gilead and�Neurocrine Biosciences (NBIX) their top picks, hile putting Buy ratings on Celgene, Biogen Idec, Alexion (ALXN), Incyte (INCY), Pharmacyclics (PCYC) and Synageva (GEVA). BioMarin (BMRN), Infinity Pharmaceuticals (INFI) and Amgen (AMGN) earned Neutral ratings.
Top 10 Tech Companies To Watch In Right Now: Iridium Communications Inc(IRDM)
Iridium Communications Inc. provides mobile voice and data communications services through satellites to businesses, the U.S. and foreign governments, non-governmental organizations, and consumers worldwide. It offers post-paid mobile voice and data satellite communications services; prepaid mobile voice satellite communications services; high-speed data services; machine-to-machine services for sending and receiving data from one location to other; and ancillary services, including inbound connections from the public switched telephone networks, SMS, SIM, activation, customer reactivation, and other peripheral services to commercial customers. The company also offers traditional voice, netted voice, data, messaging, and paging services, as well as maintenance services for the DoD?s dedicated gateway; and offers voice and data solutions, including personnel tracking devices; over-the-horizon aircraft communications applications; submarine communications applications; spec ialized communications solutions for high-value individuals; asset tracking devices for equipment, vehicles, and aircraft; and secure mobile communications and data devices for the military and intelligence community, such as secure satellite handsets to U.S. government customers. In addition, it manufactures and sells satellite handsets, voice and data modems, high-speed data devices, and machine-to-machine data devices. Further, the company offers accessories for its devices, including holsters, earbuds, portable auxiliary antennas, antenna adaptors, USB data cables, and charging units. Additionally, it provides engineering and support services to commercial and government customers. The company sells products and services to commercial end-users through service providers, value-added resellers, and value-added manufacturers. As of March 31, 2011, it had approximately 447,000 billable subscribers. The company was founded in 2000 and is headquartered in McLean, Virginia.
Advisors' Opinion:- [By John Udovich]
Jim Cramer, the host of CNBC�� Mad Money, recently touted ViaSat, Inc (NASDAQ: VSAT) as an in-flight WiFi or satellite communications related play, meaning its worth taking a closer look at the stock along with the performance of small cap in-flight WiFi provider Gogo Inc (NASDAQ: GOGO) and small cap satellite communications firm Iridium Communications Inc (NASDAQ: IRDM). I should mention that I have written about Gogo Inc in the past (Small Cap Gogo Inc (GOGO): Is There Turbulence Ahead? IRDM�and Is In-flight WiFi Stock Gogo, Inc. (GOGO) the Next Iridium?) and Cramer also touched on some of the differences between the in-flight wifi service offerings of both. Cramer also interviewed ViaSat, Inc�� CEO who said they had been waiting for a new satellite to ��isrupt��the market.
Top 10 Tech Companies To Watch In Right Now: Qualys Inc (QLYS)
Qualys, Inc. (Qualys), incorporated on December 30, 1999, is a provider of clouds security and compliance solutions that enable organizations to identify security risks to their information technology (IT) infrastructures, help protect their IT systems and applications from cyber attacks and achieve compliance with internal policies and external regulations. The Company designed its QualysGuard Cloud Platform to transform the way organizations secure and protect their IT infrastructures and applications. The Company's cloud platform offers an integrated suite of solutions that automates the lifecycle of asset discovery, security assessments, and compliance management for an organization's IT infrastructure and assets, whether they reside inside the organization, on their network perimeter or in the cloud.
The Company provides its solutions through a software-as-a-service model, primarily with renewable annual subscriptions. These subscriptions require customers to pay a fee in order to access the Company's cloud solutions. The Company's QualysGuard Cloud Platform consists of a suite of IT security and compliance solutions that leverage the Company's shared and extensible core services and its scalable multi-tenant cloud infrastructure. The Company's suite of solutions provides security intelligence by automating the life cycle of IT asset discovery, security assessment and compliance management. The Company's cloud platform's infrastructure includes integrated services that deliver a automated and scalable scanning infrastructure capable of scanning IT systems and Web applications, inside and outside corporate firewalls. The Company also provides open application program interfaces (APIs), and other developer tools that allow third parties to embed its technology into their solutions and build applications on its cloud platform.
The Company's suite of solutions, which the Company refers to as the QualysGuard Cloud Suite, includes Vulnerability Management, Web Application Sca! nning, Malware Detection Service, Policy Compliance, PCI Compliance and Qualys SECURE Seal. The Company's customers can subscribe to one or more of the Company's security and compliance solutions based on their initial needs and expand their subscriptions over time to new areas within their organization or to additional QualysGuard solutions. The Company offers two editions of its QualysGuard Cloud Suite, the Enterprise edition for large and medium-sized enterprises and the Express edition for small and medium-sized businesses.
QualysGuard Vulnerability Management (QualysGuard VM), is a solution that automates network auditing and vulnerability management across an organization, including network discovery and mapping, asset management, vulnerability reporting, and remediation tracking. QualysGuard Policy Compliance (QualysGuard PC) allows customers to analyze and collect configuration and access control information from their networked devices and Web applications and automatically maps this information to internal policies and external regulations in order to document compliance.
QualysGuard PCI Compliance (QualysGuard PCI) provides organizations that store cardholder data a automated solution to verify and document compliance with PCI DSS. QualysGuard Web Application Scanning (QualysGuard WAS) uses the scalability of its cloud platform to allow customers to discover, catalog and scan a large number of Web applications. QualysGuard Malware Detection Service (QualysGuard MDS) provides organizations with the ability to scan identify and remove malware infections from their Websites. QualysGuard Web Application Firewall (QualysGuard WAF) delivers enterprise-grade Web application security without associated with appliance-based Web application firewall solutions. QualysGuard SECURE Seal helps organizations demonstrate to their online customers that they maintain a proactive security program.
Core Services include asset tagging and management, reporting and dashboards! , questio! nnaires and collaboration, remediation and workflow, big data correlation and analytics engine, and alerts and notifications. The Company�� infrastructure layer, which it refer to as its Infrastructure, includes the data, data processing capabilities, software and hardware infrastructure and infrastructure management capabilities that provide the foundation for its cloud platform and allow the Company to automatically scale its Infrastructure and Core Services to scan millions of Internet protocols (IPs).
The Company competes with Hewlett-Packard Company, Imperva, Inc., International Business Machines Corporation, McAfee, Inc., Symantec Corporation, Barracuda Networks, Inc., BeyondTrust Software, Inc., Lumension Security, Inc., nCircle Network Security, Inc., NetIQ Corporation, Rapid7 LLC, Tenable Network Security, Inc. and Trustwave Holdings, Inc.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading UP
Qualys (NASDAQ: QLYS) shares shot up 10.23 percent to $21.07 after the company reported upbeat quarterly results.Shares of Office Depot (NYSE: ODP) got a boost, shooting up 15.95 percent to $4.84 after the company reported upbeat quarterly earnings and announced its plans to close at least 400 stores in the US.
- [By Jake L'Ecuyer]
Equities Trading UP
Qualys (NASDAQ: QLYS) shares shot up 8.24 percent to $20.68 after the company reported upbeat quarterly results.Shares of Office Depot (NYSE: ODP) got a boost, shooting up 15.95 percent to $4.84 after the company reported upbeat quarterly earnings and announced its plans to close at least 400 stores in the US.
Top 10 Tech Companies To Watch In Right Now: Intevac Inc.(IVAC)
Intevac, Inc. provides process manufacturing equipment solutions to the hard disk drive industry, and process manufacturing equipment and inspection solutions to the photovoltaic industry. The company operates in two segments, Equipment and Intevac Photonics. The Equipment segment designs, develops, and markets magnetic disks; hard disk drive equipment products, including disk sputtering and disk lubrication systems; technology upgrades; and spare parts and consumables, as well as installation, maintenance, and repair services. This segment also offers capital equipment for the photovoltaic solar manufacturing industry. The Intevac Photonics segment develops, manufactures, and sells digital-optical products for the capture and display of low-light images and materials identification used in military aircraft, ground vehicles, ground soldier head-mounted, and weapon-mounted applications. This segment also provides sensors, cameras, and systems for military applications; Ram an spectrometer table-top and handheld systems for use in forensics, homeland security, geology, gemology, medical, pharmaceutical, and industrial quality assurance applications; and low-light cameras for industrial inspection, bio-medical, and scientific applications. The company sells its products through direct sales force, system integrators, distributors, and value added resellers in the United States, Asia, Europe, and rest of world. Intevac, Inc. was founded in 1990 and is headquartered in Santa Clara, California.
Advisors' Opinion:- [By Roberto Pedone]
Intevac (IVAC) provides process manufacturing equipment solutions to the hard disk drive industry and high-productivity process manufacturing equipment and inspection solutions to the photovoltaic industry. This stock closed up 8.5% to $6.74 in Tuesday's trading session.
Tuesday's Range: $6.23-$6.75
52-Week Range: $4.06-$6.80
Tuesday's Volume: 263,000
Three-Month Average Volume: 140,032From a technical perspective, IVAC soared higher here right off some near-term support at $6.25 with above-average volume. This stock has been uptrending strong for the last three months, with shares moving higher from its low of $4.31 to its recent high of $6.80. During that move, shares of IVAC have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of IVAC within range of triggering a major breakout trade. That trade will hit if IVAC manages to take out its 52-week high at $6.80 with high volume.
Traders should now look for long-biased trades in IVAC as long as it's trending above some near-term support levels at $6.25 or at $5.92 and then once it sustains a move or close above its 52-week high at $6.80 with volume that hits near or above 140,032 shares. If that breakout hits soon, then IVAC will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are its next major overhead resistance levels at $8 to $8.37. Any high-volume move above those levels will then put $9 to $9.36 within range for shares of IVAC.
Top 10 Tech Companies To Watch In Right Now: ORBCOMM Inc.(ORBC)
ORBCOMM Inc., a wireless data communications company, operates commercial wireless messaging system optimized for narrowband data communications primarily in the United States and Japan. The company?s services enable businesses and government agencies to track, monitor, control, and communicate with fixed and mobile assets. It also provides customers with technology to monitor, manage, and remotely control refrigerated transportation assets. The company provides these services through a constellation of 27 low-Earth orbit or LEO satellites, 2 AIS microsatellites, and accompanying ground infrastructure. In addition, it offers terrestrial-based cellular communication services through reseller agreements with cellular wireless providers. The company markets and sells its products and services directly to original equipment manufacturers, government customers, and end-users, as well as through value-added resellers, international value-added resellers, international licensees , and country representatives. It serves various markets, such as commercial transportation, heavy equipment, fixed asset monitoring, marine vessels, and refrigerated transportation, as well as government and homeland security/Automatic Identification System. As of December 31, 2011, the company had approximately 648,000 billable subscriber communicators. ORBCOMM Inc. was founded in 2001 and is headquartered in Fort Lee, New Jersey.
Advisors' Opinion:- [By Garrett Cook]
Telecommunications services shares fell around 0.65 percent in trading on Monday. Top losers in the sector included NQ Mobile (NYSE: NQ), down 4 percent, and ORBCOMM (NASDAQ: ORBC), off 5 percent.
- [By Garrett Cook]
Telecommunications services shares fell around 0.65 percent in trading on Monday. Top losers in the sector included NQ Mobile (NYSE: NQ), down 4 percent, and ORBCOMM (NASDAQ: ORBC), off 5 percent.
No comments:
Post a Comment